[1]
E. Çimen, G. Kotan, K. Gören, and V. Tahiroğlu, “Integrative DFT, docking, and ADMET evaluation of a promising Schiff base inhibitor (DMBI) for tuberculosis therapy”, Bull. Chem. Soc. Eth., vol. 41, no. 1, pp. 99–118, Nov. 2026.